These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8204472)

  • 1. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study.
    van Joost T; Heule F; Korstanje M; van den Broek MJ; Stenveld HJ; van Vloten WA
    Br J Dermatol; 1994 May; 130(5):634-40. PubMed ID: 8204472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.
    Salek MS; Finlay AY; Luscombe DK; Allen BR; Berth-Jones J; Camp RD; Graham-Brown RA; Khan GK; Marks R; Motley RJ
    Br J Dermatol; 1993 Oct; 129(4):422-30. PubMed ID: 8217757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.
    Sowden JM; Berth-Jones J; Ross JS; Motley RJ; Marks R; Finlay AY; Salek MS; Graham-Brown RA; Allen BR; Camp RD
    Lancet; 1991 Jul; 338(8760):137-40. PubMed ID: 1677063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
    Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M
    Lancet; 2016 Jan; 387(10013):40-52. PubMed ID: 26454361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993.
    Camp RD; Reitamo S; Friedmann PS; Ho V; Heule F
    Br J Dermatol; 1993 Aug; 129(2):217-20. PubMed ID: 7654593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
    Harper JI; Ahmed I; Barclay G; Lacour M; Hoeger P; Cork MJ; Finlay AY; Wilson NJ; Graham-Brown RA; Sowden JM; Beard AL; Sumner MJ; Berth-Jones J
    Br J Dermatol; 2000 Jan; 142(1):52-8. PubMed ID: 10651694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon gamma therapy for atopic dermatitis.
    Hanifin JM; Schneider LC; Leung DY; Ellis CN; Jaffe HS; Izu AE; Bucalo LR; Hirabayashi SE; Tofte SJ; Cantu-Gonzales G
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):189-97. PubMed ID: 8432915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.
    Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY
    Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
    Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
    Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs--combined results from two veterinary dermatology referral centres.
    Burton G; Burrows A; Walker R; Robson D; Bassett R; Bryden S; Hill A
    Aust Vet J; 2004 Nov; 82(11):681-5. PubMed ID: 15977612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe atopic dermatitis in childhood with cyclosporin.
    Zaki I; Emerson R; Allen BR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.